Fundraising Fox

Otello Stampacchia

Investor

Managing Director at Omega Funds · Board director at Third Arc Bio · Board director at Scorpion Therapeutics · Board director at Ikena Oncology, Inc.

Switzerland

Find your path to Otello

958 people in our graph share verified history with Otello — schools, employers, funds. One of them is your warm intro.

Dave BlivinunlockedOtello: together at Duke University - The Fuqua School of Business
×8Otello: together at Northwestern University
×3Otello: together at Duke University - The Fuqua School of Business

About

Otello Stampacchia is the founder of Omega Funds, a venture capital firm focused on biotechnology. He has been involved in healthcare investing since the 1990s.

Contact· self-published, not guessed

Board director at Third Arc Bio

Intro paths

→

In turn, Otello can intro founders to Third Arc Bio's investors below.

Third Arc Bio's investors · 8

abrdn plcEdinburgh · since 2026Andreessen HorowitzMenlo Park · $500K – $50M checks · since 2024Biotechnology Value FundSan Francisco · since 2026Foresite CapitalWest Hollywood · since 2024Hillhouse InvestmentSingapore · since 2026Omega FundsBoston · since 2024T. Rowe PriceBaltimore · since 2026Vida VenturesLos Angeles · since 2024

Board director at Scorpion Therapeutics

Intro paths

→

In turn, Otello can intro founders to Scorpion Therapeutics's investors below.

Scorpion Therapeutics's investors · 9

Atlas VentureCambridge · $500K – $1M checks · since 2024Avoro Capital AdvisorsNew YorkEcoR1 CapitalSan Francisco · since 2024Frazier Life SciencesPalo AltoLightspeed Venture PartnersMenlo Park · $1.7M – $87M checksNextech InvestZurich · $648K – $3.2M checksOlive Tree CapitalBostonOmega FundsBoston · since 2024Vida VenturesLos Angeles

Co-founders at Scorpion Therapeutics

AF
Adam FriedmanExecutive Officer, Director
GGGary Glick
Gary GlickExecutive Officer, Director

Board director at Ikena Oncology, Inc.

Intro paths

→

In turn, Otello can intro founders to Ikena Oncology, Inc.'s investors below.

Ikena Oncology, Inc.'s investors · 6

Atlas VentureCambridge · $500K – $1M checks · since 2025Biotechnology Value FundSan FranciscoForesite CapitalWest HollywoodOmega FundsBoston · since 2025OrbiMedNew York · $1M – $75M checks · since 2025RTW Investments L.P.New York

Experience

  1. BioDuroChief Marketing Officercurrent2024 — presentIrvine, California, United States
  2. WuXi Chemistry (WuXi STA & WuXi TIDES)Sr. Director, Global Head for Marketing and PR2019 — 2024
  3. Catalent Pharma SolutionsGlobal Marketing Head, Oral Dose2019Somerset, NJ
  4. Catalent Pharma SolutionsGroup Product Manager, Rx & OTC Softgel2018 — 2019Somerset, NJ
  5. Catalent Pharma SolutionsProduct Manager, Rx Softgel2014 — 2018Somerset, NJ
  6. ConvaTec (Spin-off from Bristol-Myers Squibb)Manager, Global Product Marketing, Ostomy Care2013 — 2014Skillman, NJ
  7. BDGlobal Associate Strategic Marketing Manager2011 — 2012Franklin Lakes, NJ
  8. BDMBA Intern, Strategic Marketing2010BD Medical - Diabetes Care, Franklin Lakes, NJ
  9. PfizerScientist2006 — 2009R&D, Biosimilar, Lake Forest, IL
  10. AbbVieScientist2005 — 2006Global Pharmaceutical Operation, North Chicago, IL

Skills & more

Strategy7Leadership5Biotechnology30Medical Devices15Lifesciences5Cross-functional Team Leadership26FDA12Chemistry5R&D8Data Analysis6Competitive Analysis13Technology Transfer4
+6 moreCommercializationMarket AnalysisMarket ResearchDrug DevelopmentLife SciencesPharmaceutical Industry

Languages Chinese

From Otello's professional profile.

Deals · 2

ESSA PharmaBoard seat

via Omega Funds · filed Aug 2019 · $36M raise

Morphic Holding, Inc.Board seat

via Omega Funds · filed Oct 2018 · $80M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Omega Funds

Alex Delbridge
Senior Associate at Omega Funds
Anne-Mari Paster
General Partner at Omega Funds
Annie Mitsak
Partner at Cure Ventures
Benjamin Youn
Associate at Omega Funds
Bernard Davitian
Partner at Omega Funds
Claudio Nessi
Managing Director at Omega Funds
Deirdre Cunnane
COO, General Counsel at Omega Funds
Francesco Draetta
Managing Director at Omega Funds

Frequently asked questions

Who is Otello Stampacchia?
Otello Stampacchia is the founder of Omega Funds, a venture capital firm focused on biotechnology. He has been involved in healthcare investing since the 1990s.
Where does Otello Stampacchia work?
Otello Stampacchia is Managing Director at Omega Funds and Board director at Third Arc Bio and Board director at Scorpion Therapeutics and Board director at Ikena Oncology, Inc..
What boards does Otello Stampacchia sit on?
Otello Stampacchia holds tracked board seats at ESSA Pharma, Morphic Holding, Inc..
Where did Otello Stampacchia go to school?
Otello Stampacchia studied at Duke University - The Fuqua School of Business (MBA, Marketing Strategy and Product Management, Health Sector Management); Northwestern University (MS, Chemistry).

Same school

Also attended Duke University - The Fuqua School of Business250

Dave BlivinMANAGING PARTNER at Cottonwood Technology FundBrooke BalcomBoard Member at CincyTechChad SummeBoard Member at CincyTechTracie RotterPartner, Platform at Lux CapitalUlili OnovakpuriManaging Partner at Kapor CapitalLindsay MehtaDirector, Investor Relations & Marketing at JMI Equity

+ 244 more

Also attended Northwestern University584

Mikowai AshwillInvestor at Spark CapitalNaomi Pilosof IonitaBoard Partner at Menlo VenturesEric OngInvestor at LightbankBill PescatelloInvestor at LightbankScott JacobsonManaging Director at Madrona Venture GroupAnna WangAssociate at March Capital Partners

+ 578 more

Shared employers

Also worked at Catalent Pharma Solutions9

Jay FraserInvestor at Side Door VenturesBrad MorieSenior Director, Biotechnologies at Research Corporation TechnologiesPatrick StragierInvestment Manager at Meusinvest (Noshaq)Oly UgorjiAnalyst at Blueprint EquityRussell BeckermanFounder / EIR at 82VSPedro SantosPrincipal at Varsity Healthcare Partners

+ 3 more

Also worked at ConvaTec (Spin-off from Bristol-Myers Squibb)2

Kasim KutayCEO at Novo HoldingsLaura MockDirector at Cultivator Powered by Conexus

Also worked at BD36

Matthew McCooeChief Executive Officer at Connecticut InnovationsChloe GinkelAssociate at Arthur VenturesPaola RetesVice President at LiveOak VenturesMarsha HartmanExecutives in Residence at GENERAL INCEPTIONRyan LynchInvestor at Sandbox IndustriesNatalie WisniewskiCompany Building Partner at Material Impact

+ 30 more

Also worked at Pfizer229

Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital

+ 223 more